Skip to main content

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

Open Access 01-12-2010 | Oral presentation

The development of guidelines for the early recognition of foot melanoma for Podiatrists

Auteurs: Ivan Bristow, David de Berker

Gepubliceerd in: Journal of Foot and Ankle Research | bijlage 1/2010

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
insite
ZOEKEN

Introduction

The incidence of malignant melanoma (MM) continues to rise in the UK and Europe. Despite being a common form of skin cancer it is responsible for the majority of skin cancer related deaths. Around 3-15% of all cutaneous MM arise on the foot. However, lesions arising on the foot hold a poorer prognosis than melanoma elsewhere due to frequent misdiagnosis and late presentation. Initiatives to raise practitioner awareness to the problem would hopefully facilitate earlier referral and diagnosis.

Methods

Following discussions with the Faculty of Podiatric Medicine and General Practice, a panel including Dermatologists (with an interest in skin cancer) and a Podiatrist was assembled and undertook a project to produce a guide for Chiropodists/Podiatrists on the early recognition of malignant melanoma arising on the foot.

Results

Following a systematic review of published evidence and existing guidelines it was concluded there was insufficient research to fully inform such a guide. Therefore using the available literature and case reports a paper was drafted using expert opinion and clinical experience. Evaluation of reported cases of misdiagnosis and clinical features lead to the development of a new acronym specific to foot malignancy with clinical information and suggested actions. In addition, specific advice has been drafted on nail melanoma highlighting common clinical features and differential diagnosis.

Conclusion

The guide is currently being field tested amongst practitioners but should ultimately be available to all Podiatrists and Chiropodists to help raise awareness of this aggressive and often fatal disease.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Onze productaanbevelingen

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Metagegevens
Titel
The development of guidelines for the early recognition of foot melanoma for Podiatrists
Auteurs
Ivan Bristow
David de Berker
Publicatiedatum
01-12-2010
Uitgeverij
BioMed Central
Gepubliceerd in
Journal of Foot and Ankle Research / Uitgave bijlage 1/2010
Elektronisch ISSN: 1757-1146
DOI
https://doi.org/10.1186/1757-1146-3-S1-O5